|
Press Releases and Ad-hoc-Announcements 2008
July 16, 2008 |
|
MOLOGEN AG: First patient enrolled in clinical study with cancer therapy MGN1703
 more
|
May 29, 2008 |
|
MOLOGEN AG prepares start of clinical study with cancer medicine MGN1703
more
|
May 14, 2008 |
|
Successful start to the 2008 financial year for MOLOGEN AG
more
|
May 5, 2008 |
|
MOLOGEN AG receives approval for clinical study with cancer drug MGN1703
more
|
April 16, 2008 |
|
MOLOGEN AG explains voting rights announcements of the new major shareholders
more
|
March 27, 2008 |
|
MOLOGEN AG announces results for financial year 2007
more
|
March 26, 2008 |
|
MOLOGEN AG: Grant application achieves maximum score in EU funding program
more
|
January 21, 2008 |
|
MOLOGEN AG: Clarification of voting rights announcement from former Chief Executive Officer Prof. Burghardt Wittig
more
|
January 2nd, 2008 |
|
MOLOGEN AG: Supervisory Board Appoints Dr. Matthias Schroff as Chief Executive Officer
more
|
|
|
NEWSLETTER |
| To subscribe to our Newsletter please
 click here
|
|
|
PRESS
RELEASES 
